DOI:
10.1055/s-00029029
Journal of Pediatric Intensive Care
LinksClose Window
References
Fein AM, Bernard GR, Criner GJ. , et al.
Treatment of severe systemic inflammatory response syndrome and sepsis with a novel bradykinin antagonist, deltibant (CP-0127). Results of a randomized, double-blind, placebo-controlled trial. CP-0127 SIRS and sepsis study group.
JAMA 1997;
277 (06) 482-487
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.